<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02570074</url>
  </required_header>
  <id_info>
    <org_study_id>Pro00066102</org_study_id>
    <secondary_id>1UM1AI104681-01</secondary_id>
    <nct_id>NCT02570074</nct_id>
  </id_info>
  <brief_title>PK/PD and Safety/Tolerability of Two Dosing Regimens of Oral Fosfomycin Tromethamine in Healthy Adults</brief_title>
  <acronym>PROOF</acronym>
  <official_title>Phase I Study to Evaluate Pharmacokinetics, Pharmacodynamics and Safety/Tolerability of Two Dosing Regimens of Oral Fosfomycin Tromethamine in Healthy Adult Participants</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Vance Fowler, M.D.</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute of Allergy and Infectious Diseases (NIAID)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Duke University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Oral dosage regimens for fosfomycin tromethamine (Monurol™) are not established for the
      treatment of cUTI. The most common and recommended adult dosage regimen in the literature is
      a single-dose sachet containing the equivalent of 3 grams of fosfomycin administered every
      other day (QOD) for a total of three doses.

      There are a myriad of different oral fosfomycin dosing regimens currently being used in
      clinical practice, including up to 3 grams orally twice daily for 7-21 days, but these
      regimens are not based on solid pharmacokinetic, pharmacodynamic or safety rationale. Initial
      pharmacokinetic studies performed with oral fosfomycin tromethamine primarily examined single
      dose regimens and did not use modern day bioanalytical or pharmacokinetic techniques. As the
      use of fosfomycin becomes more pervasive in concordance with the increase in multidrug
      resistant pathogens, further pharmacokinetic and safety data are needed for more intensive
      dosing regimens to support its continued use.

      The rationale of this study is that oral fosfomycin tromethamine requires a modern
      pharmacokinetic-pharmacodynamic study to identify alternative oral dosage regimens that are
      appropriate and safe. This study provided safety/tolerability and clinical pharmacology
      information regarding two oral dosing regimens that may have application to treat various
      types of infections involving resistant pathogens or when other oral antibacterial options
      are not available.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study was designed as a randomized, two-way crossover trial involving up to 24 randomized
      participants with an anticipated drop-out rate no higher than 25% to give a total of 18
      evaluable healthy adult participants. The study was fully explained to each participant,
      informed consent was obtained, and an IRB-approved informed consent form was signed before
      any study procedures were initiated. All participants underwent screening assessments within
      30 days prior to the initial dosing to determine their eligibility for enrollment into the
      study. All participants met the inclusion and exclusion criteria and underwent screening
      procedures that included a complete medical history, physical examination, assessment of
      clinical laboratory parameters (chemistry and hematology), ECG, and pregnancy test (females
      of child bearing potential only).

      Randomization was stratified by gender, using permuted blocks. Within each gender, eligible
      participants were randomized with equal probability to one of the 2 treatment sequences shown
      in Table 3. According to the sequence to which the participant was randomized, the
      participant initially received one of two oral dosage regimens of fosfomycin: 3 g every other
      day x 3 doses or 3 g once-daily x 7 doses. After completion of the initial dosing regimen
      each participant was crossed over to receive the other dosing regimen. There was a minimum
      5-day, and a recommended maximum 14-day, washout period prior to starting the next dosing
      regimen. Blood and urine samples were collected throughout the study as well as detailed drug
      administration and adverse event data for each participant.

      Fosfomycin tromethamine sachet (Monurol™) was used in this study. Each participant was
      instructed how to stir and dissolve the single-dose sachet into 3 to 4 ounces of water, and
      take each dose immediately after dissolving in water. Compliance was assessed by participant
      interviews (every 2 days) and counting of empty of sachets.

      Participants reported to the outpatient study center on Day -30 to -1 for study criteria
      review, clinical assessment, and blood collection for screening laboratory tests prior to
      fosfomycin administration. Each participant participated in the study up to 120 days (i.e.,
      screening visit; day -1 for clinical assessment and blood collection; days 1-7 for fosfomycin
      administration and sample collection period; and day 8-10 for follow-up assessment; crossed
      over to receive the other dosing regimen and schedule of events.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 2016</start_date>
  <completion_date type="Actual">November 2016</completion_date>
  <primary_completion_date type="Actual">September 2016</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number (%) of Grade 2 or Higher AEs Regardless of Relationship to Study Drug</measure>
    <time_frame>3 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Day 1: Plasma PK Concentrations [mg/L]</measure>
    <time_frame>Day 1: 0, 1, 1.5, 2, 3, 4, 6, 8, 12 and 24 hours from dose</time_frame>
    <description>Day 1 mean and standard deviation plasma concentrations [mg/L] at 0, 1, 1.5, 2, 3, 4, 6, 8, 12 and 24 hours from dose</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Day 5: Plasma PK Concentrations [mg/L]</measure>
    <time_frame>Day 5: 0, 1, 1.5, 2, 3, 4, 6, 8, 12 and 24 hours from dose</time_frame>
    <description>Day 5 mean and standard deviation plasma concentrations [mg/L] at 0, 1, 1.5, 2, 3, 4, 6, 8, 12 and 24 hours from dose</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Maximum Plasma Concentration (Cmax)</measure>
    <time_frame>24 hours</time_frame>
    <description>To estimate the fosfomycin pharmacokinetic parameter maximum plasma concentration (Cmax) at steady-state for orally-dosed fosfomycin tromethamine in healthy adult participants</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Day 1: Area Under the Concentration Time Curve (AUC 0-infinity)</measure>
    <time_frame>24 hours</time_frame>
    <description>To estimate the fosfomycin pharmacokinetic parameter area-under-the-plasma concentration-time curve (AUC 0-infinity) at steady-state for orally-dosed fosfomycin tromethamine in healthy adult participants</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Day 5: Area Under the Concentration Time Curve (AUC Tau-infinity)</measure>
    <time_frame>24 hours</time_frame>
    <description>To estimate the fosfomycin pharmacokinetic parameter area-under-the-plasma concentration-time curve (AUC 0-tau) at steady-state for orally-dosed fosfomycin tromethamine in healthy adult participants</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Subjects Who Prematurely Discontinue Study Drug</measure>
    <time_frame>Dosing period: 7 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Total Body Clearance (CL)</measure>
    <time_frame>Pooled over 24 hours: Day 1</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Apparent Volume of Distribution (Vss)</measure>
    <time_frame>Pooled over 24 hours at Day 1 and Day 5</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Elimination Rate Constant (z)</measure>
    <time_frame>Pooled over 24 hours at Day 1 and Day 5</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Elimination Half-life (t½)</measure>
    <time_frame>Pooled over 24 hours at Day 1 and Day 5</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Renal Clearance (CLR)</measure>
    <time_frame>Pooled over 24 hours at Day 1 and Day 5</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Amount Excreted in the Urine (Ae)</measure>
    <time_frame>Pooled over 24 hours at Day 1 and Day 5</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Urinary Bactericidal (UBT) Titers for E. Coli ATCC 25922</measure>
    <time_frame>3 months</time_frame>
    <description>UBT for E.coli ATCC 25922</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Urinary Bactericidal Kinetics (UBK)</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Urine Fosfomycin Concentrations [mg/L]</measure>
    <time_frame>Day 1: 24 hours</time_frame>
    <description>Urine Fosfomycin concentrations [mg/L]</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>UBT-time Curve (AUBT24)</measure>
    <time_frame>24 hours at Day 1 and Day 5</time_frame>
    <description>For pathogens E. coli ATCC 25922, E. coli ATCC BAA-2323, K. pneumoniae ATCC 33495, K. pneumoniae ATCC 700603 and P. mirabilis ATCC 35659</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Urine Fosfomycin Concentrations [mg/L]</measure>
    <time_frame>Day 5: 24 hours</time_frame>
    <description>Urine Fosfomycin concentrations [mg/L]</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Urinary Bactericidal (UBT) Titers for E. Coli ATCC BAA-2323</measure>
    <time_frame>24 hours on Day 1 and Day 5</time_frame>
    <description>UBT for E. Coli ATCC BAA-2323</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Urinary Bactericidal (UBT) Titers for K. Pneumoniae ATCC 33495</measure>
    <time_frame>24 hours on Day 1 and Day 5</time_frame>
    <description>UBT for E.coli K. Pneumoniae ATCC 33495</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Urinary Bactericidal (UBT) Titers for K. Pneumoniae ATCC 700603</measure>
    <time_frame>24 hours on Day 1 and Day 5</time_frame>
    <description>UBT for K. Pneumoniae ATCC 700603</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Urinary Bactericidal (UBT) Titers for P. Mirabilis ATCC 35659</measure>
    <time_frame>24 hours on Day 1 and Day 5</time_frame>
    <description>UBT for P. Mirabilis ATCC 35659</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Urinary Inhibitory (UIT) Titers for E. Coli ATCC 25922</measure>
    <time_frame>24 hours on Day 1 and Day 5</time_frame>
    <description>UIT for E.coli ATCC 25922</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Urinary Inhibitory (UIT) Titers for E. Coli ATCC BAA-2323</measure>
    <time_frame>24 hours on Day 1 and Day 5</time_frame>
    <description>UIT for E. Coli ATCC BAA-2323</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Urinary Inhibitory (UIT) Titers for K. Pneumoniae ATCC 33495</measure>
    <time_frame>24 hours on Day 1 and Day 5</time_frame>
    <description>UIT for E.coli K. Pneumoniae ATCC 33495</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Urinary Inhibitory (UIT) Titers for K. Pneumoniae ATCC 700603</measure>
    <time_frame>24 hours on Day 1 and Day 5</time_frame>
    <description>UIT for K. Pneumoniae ATCC 700603</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Urinary Inhibitory (UIT) Titers for P. Mirabilis ATCC 35659</measure>
    <time_frame>24 hours on Day 1 and Day 5</time_frame>
    <description>UIT for P. Mirabilis ATCC 35659</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">19</enrollment>
  <condition>Healthy Subjects</condition>
  <arm_group>
    <arm_group_label>Fosfomycin - 3 doses QoD/7 doses QD</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Fosfomycin given as a 3 gm dose, every other day for 3 doses, followed by 3 gm dose, once a day for 7 doses.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Fosfomycin - 7 doses QD/3 doses QoD</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Fosfomycin given as a 3 gm dose, once a day for 7 doses, followed by 3 gm dose, every other day for 3 doses.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Fosfomycin</intervention_name>
    <description>Broad spectrum antibiotic</description>
    <arm_group_label>Fosfomycin - 3 doses QoD/7 doses QD</arm_group_label>
    <arm_group_label>Fosfomycin - 7 doses QD/3 doses QoD</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. The participant is healthy as judged by the site investigator with no clinically
             significant abnormality identified on a medical evaluation including history, physical
             examination, laboratory tests, blood pressure, and heart rate.

          2. Male and female participants between 18 to 55 years old.

          3. Female participants of childbearing potential (not surgically sterilized and between
             menarche and one-year post-menopause) must have a negative pregnancy test at the time
             of enrollment and must agree to use appropriate contraception for as long as they are
             taking the study drug and for 1 month afterwards. During the screening visit,
             participants will be instructed to use a second reliable method of birth control in
             accordance with the protocol during the study and for one month following. Medically
             acceptable contraceptives include:

               -  Surgical sterilization (such as a tubal ligation or hysterectomy)

               -  Approved hormonal contraceptives (such as birth control pills, patches, implants
                  or injections)

               -  Barrier methods (such as a condom or diaphragm) used with a spermicide, or

               -  An intrauterine device (IUD). i. NOTE: Contraceptive measures such as Plan B™,
                  sold for emergency use after unprotected sex, are not acceptable methods for
                  routine use.

          4. Nonsmokers defined as abstinence from cigarette smoking for the previous 6 months
             before enrollment into the study.

          5. Provide a signed and dated written informed consent prior to any study-specific
             procedures (including screening procedures).

          6. Body weight ≥50 kg

          7. Body mass index (BMI) 18.5-29.9 kg/m2

        Exclusion Criteria:

          1. History of significant hypersensitivity reaction or intolerance to fosfomycin
             tromethamine that in the opinion of the site investigator, contraindicates
             participation in the study. In addition, if heparin is used during pharmacokinetic
             sampling, participants with a history of sensitivity to heparin or heparin-induced
             thrombocytopenia should not be enrolled.

          2. History of significant cardiac, neurological, thyroid, muscular, or immune disorder.

          3. Any laboratory abnormality grade 2 or higher as defined according to the U.S.
             Department of Health and Human Services common terminology criteria for AEs (CTCAE).26

          4. Estimated creatinine clearance (CLCR) &lt;60 ml/minute as determined by Cockcroft-Gault
             equation

          5. Positive serum pregnancy test.

          6. Currently breast feeding.

          7. History of alcohol or substance abuse or dependence within 6 months of the screening:
             History of regular alcohol consumption averaging &gt;7 drinks/week for women or &gt;14
             drinks/week for men. 1 drink is equivalent to 12g alcohol = 5 oz (150 mL) of wine or
             12 oz (360 mL) of beer or 1.5 oz (45 mL) of 80 proof distilled spirits.

          8. The use of prescription (except birth control pills or hormone replacement in females)
             or non-prescription drugs, including herbal and dietary supplements (including St.
             John's Wort) within 7 days (or 14 days if the drug is a potential enzyme inducer) or 5
             half-lives (whichever is longer) prior to the first dose of study medication, unless
             in the opinion of site investigator the medication will not interfere with the study
             procedures or compromise participant safety.

          9. The participant has participated in a clinical trial and has received a drug or a new
             chemical entity within 30 days prior to the first dose of study medication.

         10. Participants who have donated blood to the extent where participation in the study
             would result in excess of 500 mL blood donated within a 56 day period.

         11. Those who, in the opinion of the site investigator, have a risk of non-compliance with
             study procedures.

         12. QTc interval with Fredericia correction &gt;450ms or any other clinically relevant ECG
             abnormalities
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Vance Fowler, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Duke University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Illinois at Chicago</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60612</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2019</verification_date>
  <study_first_submitted>October 6, 2015</study_first_submitted>
  <study_first_submitted_qc>October 6, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 7, 2015</study_first_posted>
  <results_first_submitted>February 17, 2019</results_first_submitted>
  <results_first_submitted_qc>July 9, 2019</results_first_submitted_qc>
  <results_first_posted type="Actual">July 30, 2019</results_first_posted>
  <last_update_submitted>July 9, 2019</last_update_submitted>
  <last_update_submitted_qc>July 9, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">July 30, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Duke University</investigator_affiliation>
    <investigator_full_name>Vance Fowler, M.D.</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fosfomycin</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Fosfomycin - 3 Doses QoD/7 Doses QD</title>
          <description>Fosfomycin given as a 3 gm dose, every other day for 3 doses, followed by 3 gm dose, once a day for 7 doses.
Fosfomycin: Broad spectrum antibiotic</description>
        </group>
        <group group_id="P2">
          <title>Fosfomycin - 7 Doses QD/3 Doses QoD</title>
          <description>Fosfomycin given as a 3 gm dose, once a day for 7 doses, followed by 3 gm dose, every other day for 3 doses.
Fosfomycin: Broad spectrum antibiotic</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Period 1 (First Dosing Regimen)</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="9"/>
                <participants group_id="P2" count="10"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="9"/>
                <participants group_id="P2" count="10"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
        <period>
          <title>Period 2 (Second Dosing Regimen)</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="9"/>
                <participants group_id="P2" count="10"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="8"/>
                <participants group_id="P2" count="10"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Fosfomycin - 3 Doses QoD/7 Doses QD</title>
          <description>Fosfomycin given as a 3 gm dose, every other day for 3 doses, followed by 3 gm dose, once a day for 7 doses.
Fosfomycin: Broad spectrum antibiotic</description>
        </group>
        <group group_id="B2">
          <title>Fosfomycin - 7 Doses QD/3 Doses QoD</title>
          <description>Fosfomycin given as a 3 gm dose, once a day for 7 doses, followed by 3 gm dose, every other day for 3 doses.
Fosfomycin: Broad spectrum antibiotic</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="9"/>
            <count group_id="B2" value="10"/>
            <count group_id="B3" value="19"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="27" lower_limit="25" upper_limit="29"/>
                    <measurement group_id="B2" value="27" lower_limit="25" upper_limit="28"/>
                    <measurement group_id="B3" value="27" lower_limit="25" upper_limit="29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="10"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="5"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="14"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="12"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                    <measurement group_id="B2" value="10"/>
                    <measurement group_id="B3" value="19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Weight</title>
          <units>kilogram</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="75.3" spread="12.3"/>
                    <measurement group_id="B2" value="76.0" spread="10.9"/>
                    <measurement group_id="B3" value="75.7" spread="11.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Entry site - University of Illinois Chicago</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                    <measurement group_id="B2" value="10"/>
                    <measurement group_id="B3" value="19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Height</title>
          <units>centimeter</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="173.2" spread="12.0"/>
                    <measurement group_id="B2" value="173.8" spread="7.9"/>
                    <measurement group_id="B3" value="173.6" spread="9.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>BMI</title>
          <units>kg/m^2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="25.0" spread="2.5"/>
                    <measurement group_id="B2" value="24.9" spread="2.4"/>
                    <measurement group_id="B3" value="24.9" spread="2.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Estimated creatinine clearance</title>
          <units>mL/min</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="105.0" spread="14.6"/>
                    <measurement group_id="B2" value="113.7" spread="23.0"/>
                    <measurement group_id="B3" value="109.6" spread="19.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>QTC Interval</title>
          <description>Average of 3 measures</description>
          <units>milliseconds</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="402.8" spread="19.7"/>
                    <measurement group_id="B2" value="405.2" spread="17.2"/>
                    <measurement group_id="B3" value="404.1" spread="17.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Number (%) of Grade 2 or Higher AEs Regardless of Relationship to Study Drug</title>
        <time_frame>3 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Fosfomycin - 3 Doses QoD Regimen</title>
            <description>The number of all AE is summarized by treatment but not sequence. The total number of subjects analyzed is 19.</description>
          </group>
          <group group_id="O2">
            <title>Fosfomycin - 7 Doses QD Regimen</title>
            <description>The number of all AE is summarized by treatment but not sequence. The total number of subjects analyzed is 19.</description>
          </group>
        </group_list>
        <measure>
          <title>Number (%) of Grade 2 or Higher AEs Regardless of Relationship to Study Drug</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="19"/>
                <count group_id="O2" value="18"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Day 1: Plasma PK Concentrations [mg/L]</title>
        <description>Day 1 mean and standard deviation plasma concentrations [mg/L] at 0, 1, 1.5, 2, 3, 4, 6, 8, 12 and 24 hours from dose</description>
        <time_frame>Day 1: 0, 1, 1.5, 2, 3, 4, 6, 8, 12 and 24 hours from dose</time_frame>
        <population>Please note that one person did not complete the Fosfomycin 3 doses QoD regimen.</population>
        <group_list>
          <group group_id="O1">
            <title>Fosfomycin - 3 Doses QoD</title>
            <description>The analysis is by Dosing Regimen</description>
          </group>
          <group group_id="O2">
            <title>Fosfomycin - 7 Doses QD</title>
            <description>The analysis is by by dosing regimen</description>
          </group>
        </group_list>
        <measure>
          <title>Day 1: Plasma PK Concentrations [mg/L]</title>
          <description>Day 1 mean and standard deviation plasma concentrations [mg/L] at 0, 1, 1.5, 2, 3, 4, 6, 8, 12 and 24 hours from dose</description>
          <population>Please note that one person did not complete the Fosfomycin 3 doses QoD regimen.</population>
          <units>mg/L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="18"/>
                <count group_id="O2" value="18"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>0 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.08" spread="0.36"/>
                    <measurement group_id="O2" value="0" spread="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 hour</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16.61" spread="5.44"/>
                    <measurement group_id="O2" value="15.90" spread="6.70"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1.5 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="22.20" spread="7.98"/>
                    <measurement group_id="O2" value="21.35" spread="7.17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="23.36" spread="7.04"/>
                    <measurement group_id="O2" value="22.12" spread="6.34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="18.72" spread="5.13"/>
                    <measurement group_id="O2" value="17.86" spread="4.67"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>4 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14.08" spread="4.00"/>
                    <measurement group_id="O2" value="13.53" spread="3.87"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.11" spread="2.38"/>
                    <measurement group_id="O2" value="8.43" spread="2.38"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>8 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.08" spread="1.48"/>
                    <measurement group_id="O2" value="5.69" spread="1.57"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.43" spread="1.01"/>
                    <measurement group_id="O2" value="3.19" spread="1.28"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>24 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.88" spread="0.59"/>
                    <measurement group_id="O2" value="1.33" spread="2.70"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Day 5: Plasma PK Concentrations [mg/L]</title>
        <description>Day 5 mean and standard deviation plasma concentrations [mg/L] at 0, 1, 1.5, 2, 3, 4, 6, 8, 12 and 24 hours from dose</description>
        <time_frame>Day 5: 0, 1, 1.5, 2, 3, 4, 6, 8, 12 and 24 hours from dose</time_frame>
        <population>Please note that one person did not complete the Fosfomycin 3 doses QoD regimen.</population>
        <group_list>
          <group group_id="O1">
            <title>Fosfomycin - 3 Doses QoD</title>
            <description>The analysis is by Dosing Regimen</description>
          </group>
          <group group_id="O2">
            <title>Fosfomycin - 7 Doses QD</title>
            <description>The analysis is by by dosing regimen</description>
          </group>
        </group_list>
        <measure>
          <title>Day 5: Plasma PK Concentrations [mg/L]</title>
          <description>Day 5 mean and standard deviation plasma concentrations [mg/L] at 0, 1, 1.5, 2, 3, 4, 6, 8, 12 and 24 hours from dose</description>
          <population>Please note that one person did not complete the Fosfomycin 3 doses QoD regimen.</population>
          <units>mg/L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="18"/>
                <count group_id="O2" value="18"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>0 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.23" spread="0.37"/>
                    <measurement group_id="O2" value="1.33" spread="1.12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 hour</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16.29" spread="6.23"/>
                    <measurement group_id="O2" value="16.81" spread="4.27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1.5 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="21.21" spread="6.91"/>
                    <measurement group_id="O2" value="22.07" spread="5.02"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="22.48" spread="6.44"/>
                    <measurement group_id="O2" value="23.37" spread="5.71"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="19.38" spread="5.34"/>
                    <measurement group_id="O2" value="19.45" spread="5.10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>4 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14.98" spread="4.82"/>
                    <measurement group_id="O2" value="15.12" spread="4.27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.78" spread="3.08"/>
                    <measurement group_id="O2" value="9.91" spread="2.74"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>8 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.47" spread="1.95"/>
                    <measurement group_id="O2" value="6.93" spread="1.96"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.71" spread="1.31"/>
                    <measurement group_id="O2" value="4.02" spread="1.61"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>24 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.82" spread="0.40"/>
                    <measurement group_id="O2" value="1.12" spread="1.07"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Maximum Plasma Concentration (Cmax)</title>
        <description>To estimate the fosfomycin pharmacokinetic parameter maximum plasma concentration (Cmax) at steady-state for orally-dosed fosfomycin tromethamine in healthy adult participants</description>
        <time_frame>24 hours</time_frame>
        <population>Please note that one person did not complete the Fosfomycin 3 doses QoD regimen.</population>
        <group_list>
          <group group_id="O1">
            <title>Fosfomycin - 3 Doses QoD Regimen</title>
            <description>The analysis is by dosing regimen.</description>
          </group>
          <group group_id="O2">
            <title>Fosfomycin - 7 Doses QD Regimen</title>
            <description>The analysis is by dosing regimen.</description>
          </group>
        </group_list>
        <measure>
          <title>Maximum Plasma Concentration (Cmax)</title>
          <description>To estimate the fosfomycin pharmacokinetic parameter maximum plasma concentration (Cmax) at steady-state for orally-dosed fosfomycin tromethamine in healthy adult participants</description>
          <population>Please note that one person did not complete the Fosfomycin 3 doses QoD regimen.</population>
          <units>mg/L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="18"/>
                <count group_id="O2" value="18"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Day 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="23.79" spread="7.48"/>
                    <measurement group_id="O2" value="23.47" spread="6.62"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 5</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="24.41" spread="6.23"/>
                    <measurement group_id="O2" value="23.75" spread="5.61"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Day 1: Area Under the Concentration Time Curve (AUC 0-infinity)</title>
        <description>To estimate the fosfomycin pharmacokinetic parameter area-under-the-plasma concentration-time curve (AUC 0-infinity) at steady-state for orally-dosed fosfomycin tromethamine in healthy adult participants</description>
        <time_frame>24 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Fosfomycin - 3 Doses QoD Regimen</title>
            <description>The analysis is by dosing regimen.</description>
          </group>
          <group group_id="O2">
            <title>Fosfomycin - 7 Doses QD Regimen</title>
            <description>The analysis is by dosing regimen.</description>
          </group>
        </group_list>
        <measure>
          <title>Day 1: Area Under the Concentration Time Curve (AUC 0-infinity)</title>
          <description>To estimate the fosfomycin pharmacokinetic parameter area-under-the-plasma concentration-time curve (AUC 0-infinity) at steady-state for orally-dosed fosfomycin tromethamine in healthy adult participants</description>
          <units>mg*hour/L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="18"/>
                <count group_id="O2" value="18"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="148.57" spread="35.57"/>
                    <measurement group_id="O2" value="176.44" spread="176.96"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Day 5: Area Under the Concentration Time Curve (AUC Tau-infinity)</title>
        <description>To estimate the fosfomycin pharmacokinetic parameter area-under-the-plasma concentration-time curve (AUC 0-tau) at steady-state for orally-dosed fosfomycin tromethamine in healthy adult participants</description>
        <time_frame>24 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Fosfomycin - 3 Doses QoD Regimen</title>
            <description>The analysis is by dosing regimen.</description>
          </group>
          <group group_id="O2">
            <title>Fosfomycin - 7 Doses QD Regimen</title>
            <description>The analysis is by dosing regimen.</description>
          </group>
        </group_list>
        <measure>
          <title>Day 5: Area Under the Concentration Time Curve (AUC Tau-infinity)</title>
          <description>To estimate the fosfomycin pharmacokinetic parameter area-under-the-plasma concentration-time curve (AUC 0-tau) at steady-state for orally-dosed fosfomycin tromethamine in healthy adult participants</description>
          <units>mg*hours/L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="18"/>
                <count group_id="O2" value="18"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="151.60" spread="35.61"/>
                    <measurement group_id="O2" value="156.62" spread="42.52"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Subjects Who Prematurely Discontinue Study Drug</title>
        <time_frame>Dosing period: 7 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Fosfomycin - 3 Doses QoD</title>
            <description>Fosfomycin given as a 3 gm dose, every other day for 3 doses.
Fosfomycin: Broad spectrum antibiotic</description>
          </group>
          <group group_id="O2">
            <title>Fosfomycin - 7 Doses QD</title>
            <description>Fosfomycin given as a 3 gm dose, once a day for 7 doses
Fosfomycin: Broad spectrum antibiotic</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Subjects Who Prematurely Discontinue Study Drug</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="19"/>
                <count group_id="O2" value="18"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Total Body Clearance (CL)</title>
        <time_frame>Pooled over 24 hours: Day 1</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Fosfomycin - 3 Doses QoD Regimen</title>
            <description>The number of all AE is summarized by regimen but not sequence. The total number of subjects analyzed is 18.</description>
          </group>
          <group group_id="O2">
            <title>Fosfomycin - 7 Doses QD Regimen</title>
            <description>The number of all AE is summarized by regimen but not sequence. The total number of subjects analyzed is 18.</description>
          </group>
        </group_list>
        <measure>
          <title>Total Body Clearance (CL)</title>
          <units>L/h</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="18"/>
                <count group_id="O2" value="18"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="21.62" spread="6.79"/>
                    <measurement group_id="O2" value="21.96" spread="6.51"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Apparent Volume of Distribution (Vss)</title>
        <time_frame>Pooled over 24 hours at Day 1 and Day 5</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Fosfomycin - 3 Doses QoD</title>
            <description>the analysis is by Dosing Regimen</description>
          </group>
          <group group_id="O2">
            <title>Fosfomycin - 7 Doses QD</title>
            <description>the analysis is by by dosing regimen</description>
          </group>
        </group_list>
        <measure>
          <title>Apparent Volume of Distribution (Vss)</title>
          <units>L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="18"/>
                <count group_id="O2" value="18"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Day 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="172.25" spread="70.41"/>
                    <measurement group_id="O2" value="143.97" spread="55.31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 5</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="140.57" spread="67.94"/>
                    <measurement group_id="O2" value="146.68" spread="67.64"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Elimination Rate Constant (z)</title>
        <time_frame>Pooled over 24 hours at Day 1 and Day 5</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Fosfomycin - 3 Doses QoD</title>
            <description>the analysis is by Dosing Regimen</description>
          </group>
          <group group_id="O2">
            <title>Fosfomycin - 7 Doses QD</title>
            <description>the analysis is by by dosing regimen</description>
          </group>
        </group_list>
        <measure>
          <title>Elimination Rate Constant (z)</title>
          <units>1/h</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="18"/>
                <count group_id="O2" value="18"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Day 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.13" spread="0.04"/>
                    <measurement group_id="O2" value="0.17" spread="0.06"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 5</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.16" spread="0.04"/>
                    <measurement group_id="O2" value="0.16" spread="0.05"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Elimination Half-life (t½)</title>
        <time_frame>Pooled over 24 hours at Day 1 and Day 5</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Fosfomycin - 3 Doses QoD</title>
            <description>the analysis is by Dosing Regimen</description>
          </group>
          <group group_id="O2">
            <title>Fosfomycin - 7 Doses QD</title>
            <description>the analysis is by by dosing regimen</description>
          </group>
        </group_list>
        <measure>
          <title>Elimination Half-life (t½)</title>
          <units>h</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="18"/>
                <count group_id="O2" value="18"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Day 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.56" spread="1.54"/>
                    <measurement group_id="O2" value="5.90" spread="7.16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 5</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.53" spread="4.09"/>
                    <measurement group_id="O2" value="7.31" spread="3.46"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Renal Clearance (CLR)</title>
        <time_frame>Pooled over 24 hours at Day 1 and Day 5</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Fosfomycin - 3 Doses QoD</title>
            <description>the analysis is by Dosing Regimen</description>
          </group>
          <group group_id="O2">
            <title>Fosfomycin - 7 Doses QD</title>
            <description>the analysis is by by dosing regimen</description>
          </group>
        </group_list>
        <measure>
          <title>Renal Clearance (CLR)</title>
          <units>L/h</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="18"/>
                <count group_id="O2" value="18"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Day 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.10" spread="3.64"/>
                    <measurement group_id="O2" value="8.09" spread="5.60"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 5</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.53" spread="4.09"/>
                    <measurement group_id="O2" value="7.31" spread="3.46"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Amount Excreted in the Urine (Ae)</title>
        <time_frame>Pooled over 24 hours at Day 1 and Day 5</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Fosfomycin - 3 Doses QoD Regimen</title>
            <description>The number of all AE is summarized by regimen but not sequence. The total number of subjects analyzed is 18.</description>
          </group>
          <group group_id="O2">
            <title>Fosfomycin - 7 Doses QD Regimen</title>
            <description>The number of all AE is summarized by regimen but not sequence. The total number of subjects analyzed is 18.</description>
          </group>
        </group_list>
        <measure>
          <title>Amount Excreted in the Urine (Ae)</title>
          <units>mg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="18"/>
                <count group_id="O2" value="18"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Day 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1047.05" spread="710.53"/>
                    <measurement group_id="O2" value="1102.34" spread="772.67"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 5</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1177.24" spread="790.76"/>
                    <measurement group_id="O2" value="1161.57" spread="718.09"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Urinary Bactericidal (UBT) Titers for E. Coli ATCC 25922</title>
        <description>UBT for E.coli ATCC 25922</description>
        <time_frame>3 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Fosfomycin - 3 Doses QoD Regimen</title>
            <description>The analysis is by dosing regimen.</description>
          </group>
          <group group_id="O2">
            <title>Fosfomycin - 7 Doses QD Regimen</title>
            <description>The analysis is by dosing regimen.</description>
          </group>
        </group_list>
        <measure>
          <title>Urinary Bactericidal (UBT) Titers for E. Coli ATCC 25922</title>
          <description>UBT for E.coli ATCC 25922</description>
          <units>Reciprocal Titers</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="19"/>
                <count group_id="O2" value="18"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Day 1, &gt;0 to 4 hr</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4" lower_limit="1" upper_limit="16"/>
                    <measurement group_id="O2" value="8" lower_limit="0" upper_limit="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 1, 4 to 8 hr</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8" lower_limit="2" upper_limit="32"/>
                    <measurement group_id="O2" value="4.5" lower_limit="0" upper_limit="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 1, 8 to 12 hr</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4" lower_limit="0" upper_limit="8"/>
                    <measurement group_id="O2" value="3" lower_limit="1" upper_limit="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 1, 12 to 24 hr</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4" lower_limit="1" upper_limit="8"/>
                    <measurement group_id="O2" value="6" lower_limit="2" upper_limit="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 5, &gt;0 to 4 hr</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4" lower_limit="1" upper_limit="16"/>
                    <measurement group_id="O2" value="4" lower_limit="1" upper_limit="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 5, 4 to 8 hr</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12" lower_limit="1" upper_limit="32"/>
                    <measurement group_id="O2" value="12" lower_limit="1" upper_limit="32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 5, 8 to 12 hr</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6" lower_limit="1" upper_limit="16"/>
                    <measurement group_id="O2" value="6" lower_limit="1" upper_limit="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 5, 12 to 24 hr</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4" lower_limit="1" upper_limit="8"/>
                    <measurement group_id="O2" value="4" lower_limit="1" upper_limit="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Urinary Bactericidal Kinetics (UBK)</title>
        <time_frame>3 months</time_frame>
        <population>Data not collected.</population>
        <group_list>
          <group group_id="O1">
            <title>Fosfomycin - 3 Doses QoD/7 Doses QD</title>
            <description>Fosfomycin given as a 3 gm dose, every other day for 3 doses, followed by 3 gm dose, once a day for 7 doses.
Fosfomycin: Broad spectrum antibiotic</description>
          </group>
          <group group_id="O2">
            <title>Fosfomycin - 7 Doses QD/3 Doses QoD</title>
            <description>Fosfomycin given as a 3 gm dose, once a day for 7 doses, followed by 3 gm dose, every other day for 3 doses.
Fosfomycin: Broad spectrum antibiotic</description>
          </group>
        </group_list>
        <measure>
          <title>Urinary Bactericidal Kinetics (UBK)</title>
          <population>Data not collected.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Urine Fosfomycin Concentrations [mg/L]</title>
        <description>Urine Fosfomycin concentrations [mg/L]</description>
        <time_frame>Day 1: 24 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Fosfomycin - 3 Doses QoD</title>
            <description>the analysis is by Dosing Regimen</description>
          </group>
          <group group_id="O2">
            <title>Fosfomycin - 7 Doses QD</title>
            <description>the analysis is by by dosing regimen</description>
          </group>
        </group_list>
        <measure>
          <title>Urine Fosfomycin Concentrations [mg/L]</title>
          <description>Urine Fosfomycin concentrations [mg/L]</description>
          <units>mg/L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="18"/>
                <count group_id="O2" value="18"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Pre-dose</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" spread="0"/>
                    <measurement group_id="O2" value="0" spread="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>0-4 hours post-Dose</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="471.71" spread="423.10"/>
                    <measurement group_id="O2" value="563.55" spread="665.94"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>4-8 hours post-dose</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="584.23" spread="348.46"/>
                    <measurement group_id="O2" value="402.90" spread="367.31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>8-12 hours post dose</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="201.99" spread="119.22"/>
                    <measurement group_id="O2" value="228.13" spread="163.30"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12-24 hours post dose</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="202.73" spread="149.08"/>
                    <measurement group_id="O2" value="175.13" spread="102.21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>UBT-time Curve (AUBT24)</title>
        <description>For pathogens E. coli ATCC 25922, E. coli ATCC BAA-2323, K. pneumoniae ATCC 33495, K. pneumoniae ATCC 700603 and P. mirabilis ATCC 35659</description>
        <time_frame>24 hours at Day 1 and Day 5</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Fosfomycin - 3 Doses QoD Regimen</title>
            <description>The number of all AE is summarized by regimen but not sequence. The total number of subjects analyzed is 18.</description>
          </group>
          <group group_id="O2">
            <title>Fosfomycin - 7 Doses QD Regimen</title>
            <description>The number of all AE is summarized by regimen but not sequence. The total number of subjects analyzed is 18.</description>
          </group>
        </group_list>
        <measure>
          <title>UBT-time Curve (AUBT24)</title>
          <description>For pathogens E. coli ATCC 25922, E. coli ATCC BAA-2323, K. pneumoniae ATCC 33495, K. pneumoniae ATCC 700603 and P. mirabilis ATCC 35659</description>
          <units>titers * hours</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="19"/>
                <count group_id="O2" value="18"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>E. coli ATCC 25922, Day 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="175.37" spread="174.30"/>
                    <measurement group_id="O2" value="158.67" spread="199.12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>E. coli ATCC 25922, Day 5</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="202.53" spread="218.71"/>
                    <measurement group_id="O2" value="196.67" spread="214.84"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>E. coli ATCC BAA-2323, Day 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="139.47" spread="140.45"/>
                    <measurement group_id="O2" value="121.56" spread="145.88"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>E. coli ATCC BAA-2323, Day 5</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="198.84" spread="219.90"/>
                    <measurement group_id="O2" value="156.33" spread="172.96"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>K. pneumoniae ATCC 33495, Day 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15.68" spread="17.75"/>
                    <measurement group_id="O2" value="11.67" spread="11.95"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>K. pneumoniae ATCC 33495, Day 5</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="20.63" spread="19.11"/>
                    <measurement group_id="O2" value="17.44" spread="16.13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>K. pneumoniae ATCC 700603, Day 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10.32" spread="8.23"/>
                    <measurement group_id="O2" value="4.56" spread="7.02"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>K. pneumoniae ATCC 700603, Day 5</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12.42" spread="8.83"/>
                    <measurement group_id="O2" value="9.89" spread="6.74"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>P. Mirabilis ATCC 35659, Day 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="96.53" spread="135.80"/>
                    <measurement group_id="O2" value="53.78" spread="70.75"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>P. Mirabilis ATCC 35659, Day 5</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="96.95" spread="148.42"/>
                    <measurement group_id="O2" value="90.33" spread="146.85"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Urine Fosfomycin Concentrations [mg/L]</title>
        <description>Urine Fosfomycin concentrations [mg/L]</description>
        <time_frame>Day 5: 24 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Fosfomycin - 3 Doses QoD</title>
            <description>the analysis is by Dosing Regimen</description>
          </group>
          <group group_id="O2">
            <title>Fosfomycin - 7 Doses QD</title>
            <description>the analysis is by by dosing regimen</description>
          </group>
        </group_list>
        <measure>
          <title>Urine Fosfomycin Concentrations [mg/L]</title>
          <description>Urine Fosfomycin concentrations [mg/L]</description>
          <units>mg/L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="18"/>
                <count group_id="O2" value="18"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Pre-dose</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="66.24" spread="102.59"/>
                    <measurement group_id="O2" value="314.34" spread="257.97"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>0-4 hours post-Dose</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="642.83" spread="521.45"/>
                    <measurement group_id="O2" value="465.74" spread="266.24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>4-8 hours post-dose</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="643.93" spread="496.86"/>
                    <measurement group_id="O2" value="608.99" spread="344.54"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>8-12 hours post dose</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="295.01" spread="272.97"/>
                    <measurement group_id="O2" value="254.75" spread="120.71"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12-24 hours post dose</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="169.51" spread="112.14"/>
                    <measurement group_id="O2" value="222.20" spread="167.87"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Urinary Bactericidal (UBT) Titers for E. Coli ATCC BAA-2323</title>
        <description>UBT for E. Coli ATCC BAA-2323</description>
        <time_frame>24 hours on Day 1 and Day 5</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Fosfomycin - 3 Doses QoD Regimen</title>
            <description>The analysis is by dosing regimen.</description>
          </group>
          <group group_id="O2">
            <title>Fosfomycin - 7 Doses QD Regimen</title>
            <description>The analysis is by dosing regimen.</description>
          </group>
        </group_list>
        <measure>
          <title>Urinary Bactericidal (UBT) Titers for E. Coli ATCC BAA-2323</title>
          <description>UBT for E. Coli ATCC BAA-2323</description>
          <units>Reciprocal Titers</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="19"/>
                <count group_id="O2" value="18"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Day 1, &gt;0 to 4 hr</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4" lower_limit="1" upper_limit="16"/>
                    <measurement group_id="O2" value="8" lower_limit="0" upper_limit="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 1, 4 to 8 hr</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8" lower_limit="2" upper_limit="16"/>
                    <measurement group_id="O2" value="2.5" lower_limit="0" upper_limit="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 1, 8 to 12 hr</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4" lower_limit="0" upper_limit="8"/>
                    <measurement group_id="O2" value="3" lower_limit="1" upper_limit="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 1, 12 to 24 hr</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2" lower_limit="1" upper_limit="4"/>
                    <measurement group_id="O2" value="4" lower_limit="2" upper_limit="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 5, &gt;0 to 4 hr</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16" lower_limit="4" upper_limit="32"/>
                    <measurement group_id="O2" value="4" lower_limit="2" upper_limit="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 5, 4 to 8 hr</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8" lower_limit="0" upper_limit="32"/>
                    <measurement group_id="O2" value="16" lower_limit="4" upper_limit="32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 5, 8 to 12 hr</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4" lower_limit="0" upper_limit="8"/>
                    <measurement group_id="O2" value="4" lower_limit="1" upper_limit="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 5, 12 to 24 hr</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4" lower_limit="1" upper_limit="4"/>
                    <measurement group_id="O2" value="4" lower_limit="2" upper_limit="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Urinary Bactericidal (UBT) Titers for K. Pneumoniae ATCC 33495</title>
        <description>UBT for E.coli K. Pneumoniae ATCC 33495</description>
        <time_frame>24 hours on Day 1 and Day 5</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Fosfomycin - 3 Doses QoD Regimen</title>
            <description>The analysis is by dosing regimen.</description>
          </group>
          <group group_id="O2">
            <title>Fosfomycin - 7 Doses QD Regimen</title>
            <description>The analysis is by dosing regimen.</description>
          </group>
        </group_list>
        <measure>
          <title>Urinary Bactericidal (UBT) Titers for K. Pneumoniae ATCC 33495</title>
          <description>UBT for E.coli K. Pneumoniae ATCC 33495</description>
          <units>Reciprocal Titers</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="19"/>
                <count group_id="O2" value="18"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Day 1, &gt;0 to 4 hr</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1" lower_limit="0" upper_limit="2"/>
                    <measurement group_id="O2" value="0" lower_limit="0" upper_limit="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 1, 4 to 8 hr</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2" lower_limit="0" upper_limit="2"/>
                    <measurement group_id="O2" value="0" lower_limit="0" upper_limit="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 1, 8 to 12 hr</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0" upper_limit="0"/>
                    <measurement group_id="O2" value="0" lower_limit="0" upper_limit="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 1, 12 to 24 hr</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0" upper_limit="1"/>
                    <measurement group_id="O2" value="1" lower_limit="0" upper_limit="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 5, &gt;0 to 4 hr</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2" lower_limit="0" upper_limit="4"/>
                    <measurement group_id="O2" value="1.5" lower_limit="0" upper_limit="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 5, 4 to 8 hr</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1" lower_limit="0" upper_limit="4"/>
                    <measurement group_id="O2" value="2" lower_limit="0" upper_limit="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 5, 8 to 12 hr</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0" upper_limit="1"/>
                    <measurement group_id="O2" value="0" lower_limit="0" upper_limit="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 5, 12 to 24 hr</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0" upper_limit="1"/>
                    <measurement group_id="O2" value="1.0" lower_limit="0" upper_limit="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Urinary Bactericidal (UBT) Titers for K. Pneumoniae ATCC 700603</title>
        <description>UBT for K. Pneumoniae ATCC 700603</description>
        <time_frame>24 hours on Day 1 and Day 5</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Fosfomycin - 3 Doses QoD Regimen</title>
            <description>The analysis is by dosing regimen.</description>
          </group>
          <group group_id="O2">
            <title>Fosfomycin - 7 Doses QD Regimen</title>
            <description>The analysis is by dosing regimen.</description>
          </group>
        </group_list>
        <measure>
          <title>Urinary Bactericidal (UBT) Titers for K. Pneumoniae ATCC 700603</title>
          <description>UBT for K. Pneumoniae ATCC 700603</description>
          <units>Reciprocal Titers</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="19"/>
                <count group_id="O2" value="18"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Day 1, &gt;0 to 4 hr</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1" lower_limit="0" upper_limit="2"/>
                    <measurement group_id="O2" value="0" lower_limit="0" upper_limit="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 1, 4 to 8 hr</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1" lower_limit="0" upper_limit="2"/>
                    <measurement group_id="O2" value="0" lower_limit="0" upper_limit="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 1, 8 to 12 hr</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0" upper_limit="1"/>
                    <measurement group_id="O2" value="0" lower_limit="0" upper_limit="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 1, 12 to 24 hr</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0" upper_limit="1"/>
                    <measurement group_id="O2" value="0" lower_limit="0" upper_limit="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 5, &gt;0 to 4 hr</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1" lower_limit="0" upper_limit="2"/>
                    <measurement group_id="O2" value="1" lower_limit="0" upper_limit="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 5, 4 to 8 hr</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1" lower_limit="0" upper_limit="2"/>
                    <measurement group_id="O2" value="1" lower_limit="0" upper_limit="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 5, 8 to 12 hr</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0" upper_limit="1"/>
                    <measurement group_id="O2" value="0" lower_limit="0" upper_limit="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 5, 12 to 24 hr</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0" upper_limit="0"/>
                    <measurement group_id="O2" value="0" lower_limit="0" upper_limit="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Urinary Bactericidal (UBT) Titers for P. Mirabilis ATCC 35659</title>
        <description>UBT for P. Mirabilis ATCC 35659</description>
        <time_frame>24 hours on Day 1 and Day 5</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Fosfomycin - 3 Doses QoD Regimen</title>
            <description>The analysis is by dosing regimen.</description>
          </group>
          <group group_id="O2">
            <title>Fosfomycin - 7 Doses QD Regimen</title>
            <description>The analysis is by dosing regimen.</description>
          </group>
        </group_list>
        <measure>
          <title>Urinary Bactericidal (UBT) Titers for P. Mirabilis ATCC 35659</title>
          <description>UBT for P. Mirabilis ATCC 35659</description>
          <units>Reciprocal Titers</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="19"/>
                <count group_id="O2" value="18"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Day 1, &gt;0 to 4 hr</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4" lower_limit="1" upper_limit="8"/>
                    <measurement group_id="O2" value="2.5" lower_limit="0" upper_limit="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 1, 4 to 8 hr</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4" lower_limit="1" upper_limit="8"/>
                    <measurement group_id="O2" value="0.5" lower_limit="0" upper_limit="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 1, 8 to 12 hr</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1" lower_limit="0" upper_limit="4"/>
                    <measurement group_id="O2" value="1" lower_limit="0" upper_limit="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 1, 12 to 24 hr</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1" lower_limit="1" upper_limit="4"/>
                    <measurement group_id="O2" value="2" lower_limit="1" upper_limit="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 5, &gt;0 to 4 hr</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4" lower_limit="1" upper_limit="8"/>
                    <measurement group_id="O2" value="4" lower_limit="0" upper_limit="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 5, 4 to 8 hr</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2" lower_limit="0" upper_limit="8"/>
                    <measurement group_id="O2" value="4" lower_limit="1" upper_limit="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 5, 8 to 12 hr</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2" lower_limit="0" upper_limit="8"/>
                    <measurement group_id="O2" value="1" lower_limit="0" upper_limit="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 5, 12 to 24 hr</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1" lower_limit="0" upper_limit="4"/>
                    <measurement group_id="O2" value="2" lower_limit="0" upper_limit="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Urinary Inhibitory (UIT) Titers for E. Coli ATCC 25922</title>
        <description>UIT for E.coli ATCC 25922</description>
        <time_frame>24 hours on Day 1 and Day 5</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Fosfomycin - 3 Doses QoD Regimen</title>
            <description>The analysis is by dosing regimen.</description>
          </group>
          <group group_id="O2">
            <title>Fosfomycin - 7 Doses QD Regimen</title>
            <description>The analysis is by dosing regimen.</description>
          </group>
        </group_list>
        <measure>
          <title>Urinary Inhibitory (UIT) Titers for E. Coli ATCC 25922</title>
          <description>UIT for E.coli ATCC 25922</description>
          <units>Reciprocal Titers</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="19"/>
                <count group_id="O2" value="18"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Day 1, &gt;0 to 4 hr</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4" lower_limit="1" upper_limit="16"/>
                    <measurement group_id="O2" value="8" lower_limit="0" upper_limit="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 1, 4 to 8 hr</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8" lower_limit="2" upper_limit="32"/>
                    <measurement group_id="O2" value="4.5" lower_limit="0" upper_limit="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 1, 8 to 12 hr</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4" lower_limit="0" upper_limit="8"/>
                    <measurement group_id="O2" value="3" lower_limit="1" upper_limit="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 1, 12 to 24 hr</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4" lower_limit="1" upper_limit="8"/>
                    <measurement group_id="O2" value="6" lower_limit="2" upper_limit="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 5, &gt;0 to 4 hr</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8" lower_limit="4" upper_limit="32"/>
                    <measurement group_id="O2" value="4" lower_limit="1" upper_limit="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 5, 4 to 8 hr</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16" lower_limit="0" upper_limit="32"/>
                    <measurement group_id="O2" value="12" lower_limit="1" upper_limit="32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 5, 8 to 12 hr</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4" lower_limit="0" upper_limit="8"/>
                    <measurement group_id="O2" value="6" lower_limit="1" upper_limit="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 5, 12 to 24 hr</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4" lower_limit="1" upper_limit="8"/>
                    <measurement group_id="O2" value="4" lower_limit="1" upper_limit="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Urinary Inhibitory (UIT) Titers for E. Coli ATCC BAA-2323</title>
        <description>UIT for E. Coli ATCC BAA-2323</description>
        <time_frame>24 hours on Day 1 and Day 5</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Fosfomycin - 3 Doses QoD Regimen</title>
            <description>The analysis is by dosing regimen.</description>
          </group>
          <group group_id="O2">
            <title>Fosfomycin - 7 Doses QD Regimen</title>
            <description>The analysis is by dosing regimen.</description>
          </group>
        </group_list>
        <measure>
          <title>Urinary Inhibitory (UIT) Titers for E. Coli ATCC BAA-2323</title>
          <description>UIT for E. Coli ATCC BAA-2323</description>
          <units>Reciprocal Titers</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="19"/>
                <count group_id="O2" value="18"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Day 1, &gt;0 to 4 hr</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4" lower_limit="1" upper_limit="16"/>
                    <measurement group_id="O2" value="8" lower_limit="0" upper_limit="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 1, 4 to 8 hr</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8" lower_limit="2" upper_limit="16"/>
                    <measurement group_id="O2" value="2.5" lower_limit="0" upper_limit="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 1, 8 to 12 hr</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4" lower_limit="0" upper_limit="8"/>
                    <measurement group_id="O2" value="3" lower_limit="1" upper_limit="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 1, 12 to 24 hr</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2" lower_limit="1" upper_limit="4"/>
                    <measurement group_id="O2" value="4" lower_limit="2" upper_limit="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 5, &gt;0 to 4 hr</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16" lower_limit="4" upper_limit="32"/>
                    <measurement group_id="O2" value="4" lower_limit="2" upper_limit="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 5, 4 to 8 hr</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8" lower_limit="0" upper_limit="32"/>
                    <measurement group_id="O2" value="16" lower_limit="4" upper_limit="32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 5, 8 to 12 hr</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4" lower_limit="0" upper_limit="8"/>
                    <measurement group_id="O2" value="4" lower_limit="1" upper_limit="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 5, 12 to 24 hr</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4" lower_limit="1" upper_limit="4"/>
                    <measurement group_id="O2" value="4" lower_limit="2" upper_limit="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Urinary Inhibitory (UIT) Titers for K. Pneumoniae ATCC 33495</title>
        <description>UIT for E.coli K. Pneumoniae ATCC 33495</description>
        <time_frame>24 hours on Day 1 and Day 5</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Fosfomycin - 3 Doses QoD Regimen</title>
            <description>The analysis is by dosing regimen.</description>
          </group>
          <group group_id="O2">
            <title>Fosfomycin - 7 Doses QD Regimen</title>
            <description>The analysis is by dosing regimen.</description>
          </group>
        </group_list>
        <measure>
          <title>Urinary Inhibitory (UIT) Titers for K. Pneumoniae ATCC 33495</title>
          <description>UIT for E.coli K. Pneumoniae ATCC 33495</description>
          <units>Reciprocal Titers</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="19"/>
                <count group_id="O2" value="18"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Day 1, &gt;0 to 4 hr</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1" lower_limit="0" upper_limit="2"/>
                    <measurement group_id="O2" value="0" lower_limit="0" upper_limit="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 1, 4 to 8 hr</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2" lower_limit="0" upper_limit="2"/>
                    <measurement group_id="O2" value="0" lower_limit="0" upper_limit="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 1, 8 to 12 hr</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0" upper_limit="0"/>
                    <measurement group_id="O2" value="0" lower_limit="0" upper_limit="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 1, 12 to 24 hr</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0" upper_limit="1"/>
                    <measurement group_id="O2" value="1" lower_limit="0" upper_limit="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 5, &gt;0 to 4 hr</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2" lower_limit="0" upper_limit="4"/>
                    <measurement group_id="O2" value="1.5" lower_limit="0" upper_limit="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 5, 4 to 8 hr</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1" lower_limit="0" upper_limit="4"/>
                    <measurement group_id="O2" value="2" lower_limit="0" upper_limit="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 5, 8 to 12 hr</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0" upper_limit="1"/>
                    <measurement group_id="O2" value="0" lower_limit="0" upper_limit="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 5, 12 to 24 hr</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0" upper_limit="1"/>
                    <measurement group_id="O2" value="1" lower_limit="0" upper_limit="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Urinary Inhibitory (UIT) Titers for K. Pneumoniae ATCC 700603</title>
        <description>UIT for K. Pneumoniae ATCC 700603</description>
        <time_frame>24 hours on Day 1 and Day 5</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Fosfomycin - 3 Doses QoD Regimen</title>
            <description>The analysis is by dosing regimen.</description>
          </group>
          <group group_id="O2">
            <title>Fosfomycin - 7 Doses QD Regimen</title>
            <description>The analysis is by dosing regimen.</description>
          </group>
        </group_list>
        <measure>
          <title>Urinary Inhibitory (UIT) Titers for K. Pneumoniae ATCC 700603</title>
          <description>UIT for K. Pneumoniae ATCC 700603</description>
          <units>Reciprocal Titers</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="19"/>
                <count group_id="O2" value="18"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Day 1, &gt;0 to 4 hr</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1" lower_limit="0" upper_limit="2"/>
                    <measurement group_id="O2" value="0" lower_limit="0" upper_limit="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 1, 4 to 8 hr</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1" lower_limit="0" upper_limit="2"/>
                    <measurement group_id="O2" value="0" lower_limit="0" upper_limit="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 1, 8 to 12 hr</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0" upper_limit="1"/>
                    <measurement group_id="O2" value="0" lower_limit="0" upper_limit="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 1, 12 to 24 hr</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0" upper_limit="1"/>
                    <measurement group_id="O2" value="0" lower_limit="0" upper_limit="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 5, &gt;0 to 4 hr</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1" lower_limit="0" upper_limit="2"/>
                    <measurement group_id="O2" value="1" lower_limit="0" upper_limit="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 5, 4 to 8 hr</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1" lower_limit="0" upper_limit="2"/>
                    <measurement group_id="O2" value="1" lower_limit="0" upper_limit="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 5, 8 to 12 hr</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0" upper_limit="1"/>
                    <measurement group_id="O2" value="0" lower_limit="0" upper_limit="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 5, 12 to 24 hr</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0" upper_limit="0"/>
                    <measurement group_id="O2" value="0" lower_limit="0" upper_limit="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Urinary Inhibitory (UIT) Titers for P. Mirabilis ATCC 35659</title>
        <description>UIT for P. Mirabilis ATCC 35659</description>
        <time_frame>24 hours on Day 1 and Day 5</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Fosfomycin - 3 Doses QoD Regimen</title>
            <description>The analysis is by dosing regimen.</description>
          </group>
          <group group_id="O2">
            <title>Fosfomycin - 7 Doses QD Regimen</title>
            <description>The analysis is by dosing regimen.</description>
          </group>
        </group_list>
        <measure>
          <title>Urinary Inhibitory (UIT) Titers for P. Mirabilis ATCC 35659</title>
          <description>UIT for P. Mirabilis ATCC 35659</description>
          <units>Reciprocal Titers</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="19"/>
                <count group_id="O2" value="18"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Day 1, &gt;0 to 4 hr</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4" lower_limit="1" upper_limit="8"/>
                    <measurement group_id="O2" value="2.5" lower_limit="0" upper_limit="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 1, 4 to 8 hr</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4" lower_limit="1" upper_limit="8"/>
                    <measurement group_id="O2" value="0.5" lower_limit="0" upper_limit="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 1, 8 to 12 hr</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1" lower_limit="0" upper_limit="4"/>
                    <measurement group_id="O2" value="1" lower_limit="0" upper_limit="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 1, 12 to 24 hr</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1" lower_limit="1" upper_limit="4"/>
                    <measurement group_id="O2" value="2" lower_limit="1" upper_limit="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 5, &gt;0 to 4 hr</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4" lower_limit="1" upper_limit="8"/>
                    <measurement group_id="O2" value="4" lower_limit="0" upper_limit="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 5, 4 to 8 hr</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2" lower_limit="0" upper_limit="8"/>
                    <measurement group_id="O2" value="4" lower_limit="1" upper_limit="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 5, 8 to 12 hr</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2" lower_limit="0" upper_limit="8"/>
                    <measurement group_id="O2" value="1" lower_limit="0" upper_limit="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 5, 12 to 24 hr</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1" lower_limit="0" upper_limit="4"/>
                    <measurement group_id="O2" value="2" lower_limit="0" upper_limit="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Adverse event data were collected though 60 days following the final study visit</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Fosfomycin - 3 Doses QoD</title>
          <description>Fosfomycin given as a 3 gm dose, every other day for 3 doses
Fosfomycin: Broad spectrum antibiotic</description>
        </group>
        <group group_id="E2">
          <title>Fosfomycin - 7 Doses QD</title>
          <description>Fosfomycin given as a 3 gm dose, once a day for 7 doses
Fosfomycin: Broad spectrum antibiotic</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="18"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="19"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="18"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Clostridium difficile colitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="18"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>Transaminases increased</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="19"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="18"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="16" subjects_at_risk="19"/>
                <counts group_id="E2" subjects_affected="16" subjects_at_risk="18"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Ear and labyrinth disorders</title>
            <event_list>
              <event>
                <sub_title>Tinnitus</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="18"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Abdominal Pain</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="19"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="18"/>
              </event>
              <event>
                <sub_title>Abdominal distension</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="19"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="18"/>
              </event>
              <event>
                <sub_title>Diarrhoea</sub_title>
                <counts group_id="E1" events="15" subjects_affected="15" subjects_at_risk="19"/>
                <counts group_id="E2" events="16" subjects_affected="16" subjects_at_risk="18"/>
              </event>
              <event>
                <sub_title>Nausea</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="19"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="18"/>
              </event>
              <event>
                <sub_title>Vomiting</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="19"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="18"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Fatigue</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="19"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="18"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Sinusitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="18"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Headache</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="19"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="18"/>
              </event>
              <event>
                <sub_title>Tremor</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="18"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Anxiety</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="18"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Dysuria</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="19"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="18"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Oropharyngeal pain</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="19"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="18"/>
              </event>
              <event>
                <sub_title>Sinus Congestion</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="19"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="18"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Dermatitis contact</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="19"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="18"/>
              </event>
              <event>
                <sub_title>Madarosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="19"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="18"/>
              </event>
              <event>
                <sub_title>Dry skin</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="18"/>
              </event>
              <event>
                <sub_title>Rash</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="18"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Keith A. Rodvold, PharmD, FCCP, FIDSA</name_or_title>
      <organization>University of Illinois at Chicago</organization>
      <phone>312-996-3341</phone>
      <email>kar@uic.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

